IRadimed Corporation
IRMD
$72.69
$1.191.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.18% | -8.93% | 1.93% | 3.03% | 18.49% |
| Total Depreciation and Amortization | 6.90% | -0.41% | -1.37% | -0.75% | -11.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -79.20% | 242.96% | -41.69% | 182.61% | -158.16% |
| Change in Net Operating Assets | 170.12% | -1,078.74% | -93.21% | 28.20% | 220.31% |
| Cash from Operations | 80.48% | -28.31% | -34.32% | 37.32% | 70.95% |
| Capital Expenditure | 28.72% | -32.52% | 26.77% | -235.89% | -319.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 14.47% | 17.55% | -32.31% | -48.71% | 34.92% |
| Cash from Investing | 27.92% | -28.15% | 23.80% | -215.92% | -165.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | 17.45% | 78.56% | -2,947.75% | 72.14% | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | -13.69% | -0.04% | -0.05% | 76.18% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.89% | 5.78% | -26.02% | 2.14% | 75.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 240.04% | -471.03% | -83.90% | -6.53% | 173.53% |